Are you Dr. Weisman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 88 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd.
Los Angeles, CA 90048Phone+1 310-423-2170Fax+1 310-423-6898
Summary
- Dr. Michael Weisman, MD is a rheumatologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Cedars-Sinai Medical Center and is a Professor at UCLA School of Medicine.
Education & Training
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1969 - 1973
- University of California (San Diego) Medical CenterInternship, Transitional Year, 1968 - 1969
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1968
Certifications & Licensure
- CA State Medical License 1970 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis Start of enrollment: 2010 May 01
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis Start of enrollment: 2011 Jan 01
- One-Time DNA Study for Vasculitis Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsIncidence of Ankylosing Spondylitis Among Male and Female United States Army Personnel.D. Alan Nelson, Robert M. Kaplan, Lianne M. Kurina, Michael H. Weisman
Arthritis Care & Research. 2021-08-30 - 656 citationsInteraction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibilityDavid M. Evans, Spencer Cca., J J Pointon, Zhan Su, D Harvey
Nature Genetics. 2011-08-01 - 622 citationsIdentification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.Adrian Cortes, Johanna Hadler, J.P. Pointon, Philip Robinson, Tugce Karaderi
Nature Genetics. 2013-06-09
Press Mentions
- Device Implants Need Better Labels, Advisers Tell FDANovember 15th, 2019
- Modern Medical Terms Are Still Named After Nazi Doctors. Can We Change It?November 15th, 2012
- Promising Drug Proves Ineffective as Treatment for Hearing LossOctober 8th, 2003
- Join now to see all
Grant Support
- Inflammatory Markers In The Stool And Serum Of Patients With Ankylosing SpondyliNational Center For Research Resources2010
- Project 3: Defining The Spectrum Of Spondyloarthritis In Family MembersNational Center For Research Resources2009–2010
- Genetic Susceptibility To Lipid-Lowering Drug-Induced MyopathiesNational Center For Research Resources2009–2010
- A Comprehensive Model Of Severity In Outcomes In Ankylosing SpondylitisNational Center For Research Resources2008–2010
- Rheumatoid Arthritis Associated Autoimmunity In High Risk PopulationsNational Center For Research Resources2006–2010
- Clinical Trial: Behavioral Treatments For Rheumatoid ArthritisNational Center For Research Resources2008–2009
- Genetic Determinants Of Ankylosing Spondylitis Severity: Cross Sectional StudyNational Center For Research Resources2004–2008
- Behavioral Treatments For Rheumatoid ArthritisNational Center For Research Resources2005–2007
- Efficacy Of CAM Intervention In Rheumatoid ArthritisNational Center For Research Resources2006
- Rheumatoid Arthritis Associated Autoimmunity In High Risk Populations:StudNational Center For Research Resources2005
- Family Studies Of Microsatellite Gene Markers In Patients With AnkylosingNational Center For Research Resources2004–2005
- Genetic Determinants Of Ankylosing Spondylitis SeverityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2005
- Leflunomide VS Placebo For Active Rheumatoid ArthritisNational Center For Research Resources2000–2002
- Ro32 3555 Trocade In Structural Joint Damage In Rheumatoid ArthritisNational Center For Research Resources1999–2002
- Hydroxychloroquine Or Acetaminophen In Nodal ArthritisNational Center For Research Resources1999–2002
- LJP 394 Administered To Patients With Systemic Lupus ErythematosusNational Center For Research Resources1998–2002
- Anti TNF Chimeric Monoclonal Antibody In Acute Rheumatoid ArthritisNational Center For Research Resources1998–2002
- Family Studies Of Microsatellite Gene Markers In Ankylosing SpondylitisNational Center For Research Resources2000
- Recombinant Human Interleukin Eleven In Rheumatoid ArthritisNational Center For Research Resources1999
- Induction Course &Maintenance Cycle Of Ag4263 In Rheumatoid ArthritisNational Center For Research Resources1999
- Anti TNF Antibody D2e7 IV Injection In Rheumatoid ArthritisNational Center For Research Resources1999
- Sc56835 For Treatment Of Osteoarthritis And Rheumatoid ArthritisNational Center For Research Resources1998–1999
- Oral Colloral In Patients With Rheumatoid ArthritisNational Center For Research Resources1998–1999
- Long Term Observation Of Patients With Early Rheumatoid ArthritisNational Center For Research Resources1998–1999
- Stnfr551gg And Methotrexate In Treating Patients With ArthritisNational Center For Research Resources1997–1999
- Sb210396 In Treatment Of Rheumatoid ArthritisNational Center For Research Resources1996–1999
- Psychosocial Aspects Of SclerodermaNational Center For Research Resources1996–1999
- DHEA For Treatment Of Systemic Lupus ErythematosusNational Center For Research Resources1996–1999
- Study Of Oral Ccii In Treatment Of Active Rheumatoid ArthritisNational Center For Research Resources1995–1999
- Recombinant Human Interleukin Eleven In Active Rheumatoid ArthritisNational Center For Research Resources1998
- Osteoarthritis Safety And Pilot Efficacy Study Of L 748,731National Center For Research Resources1996–1997
- D-Penicillamine In Systemic SclerosisNational Center For Research Resources1995–1997
- 2cda In The Treatment Of Psoriatic Arthritis And PsoriasisNational Center For Research Resources1995–1997
- Pharmacodynamic Effective Of Single Dose Of Ljp394 In SLENational Center For Research Resources1996
- Ljp394 In Patients With Systemic Lupus ErythematosusNational Center For Research Resources1996
- Three Loading Doses Of Hydroxychloroquine In Rheumatoid ArthritisNational Center For Research Resources1995–1996
- Three Dosage Regimens Of Stnfr-Igg In Rheumatoid ArthritisNational Center For Research Resources1995–1996
- Magnesium Repletion &Cyclobenzaprine In Eosinophilia Myalgia SyndromeNational Center For Research Resources1995–1996
- 2-Chlorodeoxyadenosine Infusion Therapy In Rheumatoid ArthritisNational Center For Research Resources1995–1996
- Tenidap Sodium And Piroxicam On Biochemical And Tissue Markers In RANational Center For Research Resources1995
- Safety And Efficacy Of Tolrestat In Limited Joint Mobility In DiabeticsNational Center For Research Resources1995
- Safety And Efficacy Of Delfazacort In Rheumatoid Arthritis, Pmr, DermatomyositisNational Center For Research Resources1995
- Phase II Study Of Chimeric Anti-Cd4 And Methotrexate In Rheumatoid ArthritisNational Center For Research Resources1995
- Rheumatoid Arthritis And Osteoporosis--Piroxicam To Suppress RA DiseaseNational Center For Research Resources1985
- Relationship Of Breast Augmentatin And Connective Tissue DiseaseNational Center For Research Resources1985
- Oral Chrysotherapeutic Of Systemic Lupus ErythematosusNational Center For Research Resources1985
- Efficacy Of Oral GOLD (AURANOFIN) In Treatment Of Rheumatoid ArthritisNational Center For Research Resources1985
- Double-Blind Comparison Of Injectable Versus Oral GOLDNational Center For Research Resources1985
- Dietary Management Of Rheumatoid ArthritisNational Center For Research Resources1985
- Calcium Pyrophosphate Dihydrate Deposition (CPPD) DiseaseNational Center For Research Resources1985
Professional Memberships
- Member